Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019104 220006575 null 37.2 Palliative (P) 2013-10-02 2013-10-31 null N N 220025166 NOT MATCHED
220019105 220006576 1.66 15.85 Curative (C) 2016-04-23 2016-06-06 ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE N N 220025171 NOT MATCHED
220019106 220006577 1.88 null Disease modification (D) 2015-07-31 2015-08-01 Hydroxycarbamide N N 220025174 HYDROXYCARBAMIDE
220019107 220013596 null 76.1 Curative (C) 2017-01-13 2017-01-13 AML Relapsed FLA - DaunoXome N null 220025180 NOT MATCHED
220019108 220006586 null null Curative (C) null 2017-07-03 APML Consolidation I ATRA,Cytarabine,Mitoxantrone N N 220025218 NOT MATCHED
220019109 220006593 null 63 null 2015-03-25 2016-05-27 Cytarabine Low Dose N N 220025249 CYTARABINE
220019110 220006596 1.83 99.4 Curative (C) 2015-01-28 2015-02-11 AML Downs HA N N 220025304 NOT MATCHED
220019111 220006598 1.52 76.4 Curative (C) 2014-10-04 2015-01-06 ALL Ph+ve Imatinib alone N N 220025310 NOT MATCHED
220019112 220020782 1.75 null Palliative (P) 2014-11-14 2015-03-21 Hydroxycarbamide N N 220025320 HYDROXYCARBAMIDE
220019113 220006600 0 68 Disease modification (D) 2017-02-21 2017-02-21 CYTARABINE 2 N 220025327 CYTARABINE
220019114 220006605 1.5 56.8 Curative (C) 2014-09-15 2014-09-21 Hydroxycarbamide 99 N 220025345 HYDROXYCARBAMIDE
220019115 220013612 null 71.5 Palliative (P) 2016-05-20 2016-05-20 AML MyeChild 01 B Cytarabine/Daunoxome + GO N Y 220025353 NOT MATCHED
220019116 220013615 null 64.7 null 2015-12-18 2016-02-08 Hydroxycarbamide Y N 220025361 HYDROXYCARBAMIDE
220019117 220006612 1.63 null Disease modification (D) 2014-02-19 2014-05-15 AML MyeChild 01 FLA-Idarubicin N N 220025362 NOT MATCHED
220019118 220006613 0.96 64.3 Palliative (P) 2016-01-22 2016-01-22 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE N N 220025362 NOT MATCHED
220019120 220013620 1.56 null Curative (C) 2017-05-17 2017-05-19 Cytarabine Intrathecal (any age) null N 220025373 CYTARABINE
220019121 220013621 null 53 Palliative (P) 2017-05-26 2017-06-02 BMT Fludarabine/Thiotepa/Treosulfan + ATG Y N 220025384 NOT MATCHED
220019122 220006622 null 59.8 null 2017-03-01 2017-03-06 Hydroxycarbamide 02 N 220025386 HYDROXYCARBAMIDE
220019124 220013624 null 88 Curative (C) 2014-07-21 2014-07-21 Hydroxycarbamide 99 N 220025400 HYDROXYCARBAMIDE
220019125 220017430 1.72 74 Palliative (P) 2015-06-10 2015-06-10 Hydroxycarbamide 2 null 220025401 HYDROXYCARBAMIDE
220019126 220006631 null null Curative (C) 2015-05-31 2015-06-03 Cytarabine low (10to20mg/m2) IV/SC 2 N 220025417 CYTARABINE
220019127 220006635 null null Palliative (P) 2016-11-17 2016-11-17 Cytarabine Low Dose N N 220025424 CYTARABINE
220019128 220013629 1.63 null Curative (C) 2015-10-20 2015-10-20 AML Interim Guidelines FLA -Ida null N 220025425 NOT MATCHED
220019129 220006638 null 87.1 Curative (C) 2017-03-08 2017-03-08 CYTARABINE N null 220025428 CYTARABINE
220019130 220006640 0 81.6 Curative (C) 2014-10-05 2014-12-18 CYTARABINE 99 N 220025439 CYTARABINE
220019131 220006645 null 52.5 Curative (C) 2016-05-21 2017-02-17 Hydroxycarbamide 2 N 220025472 HYDROXYCARBAMIDE
220019132 220006646 0 60.5 Disease modification (D) 2014-08-11 2014-10-20 FBC Conditionining Y N 220025474 NOT MATCHED
220019133 220013638 1.7 75.5 Palliative (P) 2018-03-26 2018-03-27 Cytarabine Intrathecal (any age) N null 220025481 CYTARABINE
220019135 220013640 1.51 79 Curative (C) null 2015-12-06 Cytarabine low (10to20mg/m2) IV/SC N N 220025484 CYTARABINE
220019136 220017440 1.66 22.9 Curative (C) 2018-06-08 2018-06-26 null 2 N 220025487 NOT MATCHED
220019137 220006653 null null Palliative (P) 2016-12-15 2017-04-21 Hydroxycarbamide y N 220025491 HYDROXYCARBAMIDE
220019138 220006654 null 64.3 Curative (C) 2013-06-08 2013-08-22 Cytarabine Low Dose N N 220025496 CYTARABINE
220019139 220006654 1.75 null Palliative (P) 2013-09-28 2013-11-14 FBC Conditionining 02 N 220025496 NOT MATCHED
220019140 220006659 1.67 null Curative (C) 2014-02-26 2014-02-26 Cytarabine low (10to20mg/m2) IV/SC N N 220025521 CYTARABINE
220019141 220006661 1.68 69.5 Disease modification (D) 2018-06-19 2018-06-22 Hydroxycarbamide Y N 220025523 HYDROXYCARBAMIDE
220019143 220019569 null 55 Disease modification (D) 2014-01-21 2014-01-22 Cytarabine low (10to20mg/m2) IV/SC 02 N 220025532 CYTARABINE
220019144 220006666 0 78 Palliative (P) 2017-04-01 2017-04-01 Hydroxycarbamide N N 220025542 HYDROXYCARBAMIDE
220019145 220006668 1.74 0 Palliative (P) null 2018-04-20 Hydroxycarbamide N null 220025586 HYDROXYCARBAMIDE
220019146 220006671 1.78 0 Adjuvant (A) 2017-09-29 2017-09-29 Hydroxycarbamide N null 220025591 HYDROXYCARBAMIDE
220019147 220006671 0 54 Disease modification (D) 2016-11-18 2017-03-20 APML Consolidation I ATRA,Cytarabine,Mitoxantrone N N 220025591 NOT MATCHED
220019148 220006673 null 71.1 Adjuvant (A) null 2015-02-12 Hydroxycarbamide N N 220025607 HYDROXYCARBAMIDE
220019149 220006674 0 19.9 Curative (C) 2014-07-20 2014-07-21 null Y N 220025621 NOT MATCHED
220019151 220006678 null 61.2 Disease modification (D) 2017-08-11 2017-08-11 Hydroxycarbamide Y null 220025638 HYDROXYCARBAMIDE
220019152 220006680 1.8 76 Disease modification (D) 2015-02-23 2015-02-23 CYTARABINE Y N 220025645 CYTARABINE
220019154 220013667 1.78 96.1 Curative (C) 2019-02-05 2019-02-05 Hydroxycarbamide 02 N 220025668 HYDROXYCARBAMIDE
220019155 220006688 null 83.2 Curative (C) 2015-08-11 2015-08-11 CYTARABINE Y N 220025677 CYTARABINE
220019157 220006701 null 63 null 2014-07-03 2014-07-31 Cytarabine low (10to20mg/m2) IV/SC Y N 220025732 CYTARABINE
220019160 220006705 1.6 null Disease modification (D) 2013-08-18 2013-08-22 Hydroxycarbamide N N 220025756 HYDROXYCARBAMIDE
220019161 220006707 0 35.8 Palliative (P) 2014-11-16 2015-02-18 AML Interim Guidelines FLA -Ida N N 220025764 NOT MATCHED
220019162 220006708 null 33.7 Curative (C) 2013-10-14 2013-10-14 AML MyeChild 01 IT Cyt N N 220025767 NOT MATCHED